| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
| 2006 | Association between the apolipoprotein E genotypes and breast cancer patients in Taiwanese | Chang S.-J.; Hou M.-F.; Tsai S.-M.; JAU-TSUEN KAO ; Wu S.-H.; Hou L.A.; Tsai L.-Y. | Breast Cancer Research and Treatment | | | |
| 2006 | Breast cancer risk associated with genotypic polymorphism of the genes involved in the estrogen-receptor-signaling pathway: A multigenic study on cancer susceptibility | Yu J.-C.; Hsu H.-M.; Chen S.-T.; Hsu G.-C.; CHIUN-SHENG HUANG ; Hou M.-F.; Fu Y.-P.; Cheng T.-C.; Wu P.-E.; Shen C.-Y. | Journal of Biomedical Science | | | |
| 2021 | Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AML | Tsai C.-H.; Tang J.-L.; FENG-MING TIEN ; Kuo Y.-Y.; Wu D.-C.; Lin C.-C.; Tseng M.-H.; Peng Y.-L.; Hou M.-F.; Chuang Y.-K.; Liu M.-C.; Liu C.-W.; Yao M.; Lin L.-I.; Chou W.-C.; Chen C.-Y.; Hou H.-A.; Tien H.-F. | Blood Advances | | | |
| 2021 | Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AML | Tsai C.-H.; Tang J.-L.; Tien F.-M.; Kuo Y.-Y.; Wu D.-C.; Lin C.-C.; Tseng M.-H.; Peng Y.-L.; Hou M.-F.; Chuang Y.-K.; Liu M.-C.; Liu C.-W.; Yao M.; Lin L.-I.; Chou W.-C.; Chen C.-Y.; HSIN-AN HOU ; Tien H.-F. | Blood Advances | | | |
| 2013 | Common genetic determinants of breast-cancer risk in east asian women: A collaborative study of 23 637 breast cancer cases and 25 579 controls | Zheng W.; Zhang B.; Cai Q.; Sung H.; Michailidou K.; Shi J.; Choi J.-Y.; Long J.; Dennis J.; Humphreys M.K.; Wang Q.; Lu W.; Gao Y.-T.; Li C.; Cai H.; Park S.K.; Yoo K.-Y.; Noh D.-Y.; Han W.; Dunning A.M.; Benitez J.; Vincent D.; Bacot F.; Tessier D.; Kim S.-W.; Lee M.H, Lee J.W, Lee J.-Y.; Xiang Y.-B.; Zheng Y.; Wang W.; Ji B.-T.; Matsuo K.; Ito H.; Iwata H.; Tanaka H.; Wu A.H.; Tseng C.-C.; Van Den Berg D.; Stram D.O.; Teo S.H, Yip C.H, Kang I.N, Wong T.Y.; Shen C.-Y.; Yu J.-C.; CHIUN-SHENG HUANG ; Hou M.-F.; Hartman M.; Miao H.; Lee S.C, Putti T.C, Muir K.; Lophatananon A.; Stewart-Brown S.; Siriwanarangsan P.; Sangrajrang S.; Shen H.; Chen K.; Wu P.-E.; Ren Z.; Haiman C.A.; Sueta A.; Kim M.K, Khoo U.S, Iwasaki M.; Pharoah P.D.P.; Wen W.; Hall P.; Shu X.-O.; Easton D.F.; Kang D. | Human Molecular Genetics | 79 | | |
| 2013 | Comparison of baseline quality of life scores in patients with bone and brain metastases as assessed using the EORTC QLQ-C30 | Poon M.; Zeng L.; Zhang L.; Tseng L.-M.; Hou M.-F.; Fairchild A.; Vassiliou V.; Jesus-Garcia R.; Alm El-Din M.A.; Kumar A.; Forges F.; WEI-CHU CHIE ; Sahgal A.; Wong E.; Chow E. | Journal of Pain Management | | | |
| 2013 | Comparison of baseline quality of life scores in patients with bone and brain metastases as assessed using the EORTC QLQ-C30 | Poon M.; Zeng L.; Zhang L.; Tseng L.-M.; Hou M.-F.; Fairchild A.; Vassiliou V.; Jesus-Garcia R.; Alm El-Din M.A.; Kumar A.; Forges F.; WEI-CHU CHIE ; Sahgal A.; Wong E.; Chow E. | Advanced Cancer: Managing Symptoms and Quality of Life | | | |
| 2011 | Confirmation of 5p12 as a susceptibility locus for progesterone-receptor- positive, lower grade breast cancer | Milne R.L.; Goode E.L.; Garc?a-Closas M.; Couch F.J.; Severi G.; Hein R.; Fredericksen Z.; Malats N.; Zamora M.P.; P?rez J.I.A.; Ben?tez J.; D?rk T.; Sch?rmann P.; Karstens J.H.; Hillemanns P.; Cox A.; Brock I.W.; Elliot G.; Cross S.S.; Seal S.; Turnbull C.; Renwick A.; Rahman N.; Shen C.-Y.; Yu J.-C.; CHIUN-SHENG HUANG ; Hou M.-F.; Nordestgaard B.G.; Bojesen S.E.; Lanng C.; Aln?s G.G.; Kristensen V.; B?rrensen-Dale A.-L.; Hopper J.L.; Dite G.S.; Apicella C.; Southey M.C.; Lambrechts D.; Yesilyurt B.T.; Floris G.; Leunen K.; Sangrajrang S.; Gaborieau V.; Brennan P.; McKay J.; Chang-Claude J.; Wang-Gohrke S.; Radice P.; Peterlongo P.; Manoukian S.; Barile M.; Giles G.G.; Baglietto L.; John E.M.; Miron A.; Chanock S.J.; Lissowska J.; Sherman M.E.; Figueroa J.D.; Bogdanova N.V.; Antonenkova N.N.; Zalutsky I.V.; Rogov Y.I.; Fasching P.A.; Bayer C.M.; Ekici A.B.; Beckmann M.W.; Brenner H.; M?ller H.; Arndt V.; Stegmaier C.; Andrulis I.L.; Knight J.A.; Glendon G.; Mulligan A.M.; Mannermaa A.; Kataja V.; Kosma V.-M.; Hartikainen J.M.; Meindl A.; Heil J.; Bartram C.R.; Schmutzler R.K.; Thomas G.D.; Hoover R.N.; Fletcher O.; Gibson L.J.; Dos Santos Silva I.; Peto J.; Nickels S.; Flesch-Janys D.; Anton-Culver H.; Ziogas A.; Sawyer E.; Tomlinson I.; Kerin M.; Miller N.; Schmidt M.K.; Broeks A.; Van't Veer L.J.; Tollenaar R.A.E.M.; Pharoah P.D.P.; Dunning A.M.; Pooley K.A.; Marme F.; Schneeweiss A.; Sohn C.; Burwinkel B.; Jakubowska A.; Lubinski J.; Jaworska K.; Durda K.; Kang D.; Yoo K.-Y.; Noh D.-Y.; Ahn S.-H.; Hunter D.J.; Hankinson S.E.; Kraft P.; Lindstrom S.; Chen X.; Beesley J.; Hamann U.; Harth V.; Justenhoven C.; Winqvist R.; Pylk?s K.; Jukkola-Vuorinen A.; Grip M.; Hooning M.; Hollestelle A.; Oldenburg R.A.; Tilanus-Linthorst M.; Khusnutdinova E.; Bermisheva M.; Prokofieva D.; Farahtdinova A.; Olson J.E.; Wang X.; Humphreys M.K.; Wang Q.; Chenevix-Trench G.; Easton D.F. | Cancer Epidemiology Biomarkers and Prevention | | | |
| 2013 | Determinants of quality of life in advanced cancer patients with bone metastases undergoing palliative radiation treatment | Lam K.; Chow E.; Zhang L.; Wong E.; Bedard G.; Fairchild A.; Vassiliou V.; El-Din M.A.; Jesus-Garcia R.; Kumar A.; Forges F.; Tseng L.-M.; Hou M.-F.; WEI-CHU CHIE ; Bottomley A. | Supportive Care in Cancer | | | |
| 2021 | Differential whole-genome doubling and homologous recombination deficiencies across breast cancer subtypes from the Taiwanese population | Wu C.-H.; Hsieh C.-S.; Chang Y.-C.; Huang C.-C.; Yeh H.-T.; Hou M.-F.; Chung Y.-C.; Tu S.-H.; Chang K.-J.; Chattopadhyay A.; Liang-Chuan Lai ; Lu T.-P.; Li Y.-H.; Tsai M.-H.; Chuang E.Y. | Communications Biology | | | |
| 2021 | Differential whole-genome doubling and homologous recombination deficiencies across breast cancer subtypes from the Taiwanese population | Wu C.-H.; Hsieh C.-S.; Chang Y.-C.; Huang C.-C.; Yeh H.-T.; Hou M.-F.; Chung Y.-C.; Tu S.-H.; Chang K.-J.; Chattopadhyay A.; Lai L.-C.; TZU-PIN LU ; Li Y.-H.; Tsai M.-H.; Chuang E.Y. | Communications Biology | | | |
| 2022 | Distinct clinico-biological features in AML patients with low allelic ratio FLT3-ITD: role of allogeneic stem cell transplantation in first remission | FENG-MING TIEN ; Tsai C.-H.; Huang S.-C.; Liu J.-H.; Chen C.-Y.; Kuo Y.-Y.; Chuang Y.-K.; Tseng M.-H.; Peng Y.-L.; Liu M.-C.; Liu C.-W.; Liao X.-W.; Lin L.-I.; Wu Y.-S.; Hou M.-F.; Wu S.-J.; Hsu S.-C.; Ko B.-S.; Chou W.-C.; Yao M.; Hou H.-A.; Tang J.-L.; Tien H.-F. | Bone Marrow Transplantation | | | |
| 2021 | Distinct clinico-biological features in AML patients with low allelic ratio FLT3-ITD: role of allogeneic stem cell transplantation in first remission | Tien F.-M.; Tsai C.-H.; Huang S.-C.; Liu J.-H.; Chen C.-Y.; Kuo Y.-Y.; Chuang Y.-K.; Tseng M.-H.; Peng Y.-L.; Liu M.-C.; Liu C.-W.; Liao X.-W.; Lin L.-I.; Wu Y.-S.; Hou M.-F.; Wu S.-J.; Hsu S.-C.; Ko B.-S.; Chou W.-C.; Yao M.; HSIN-AN HOU ; Tang J.-L.; Tien H.-F. | Bone Marrow Transplantation | | | |
| 2022 | Distinct clinico-biological features in AML patients with low allelic ratio FLT3-ITD: role of allogeneic stem cell transplantation in first remission | Tien F.-M.; Tsai C.-H.; Huang S.-C.; JIA-HAU LIU ; Chen C.-Y.; Kuo Y.-Y.; Chuang Y.-K.; Tseng M.-H.; Peng Y.-L.; Liu M.-C.; Liu C.-W.; Liao X.-W.; Lin L.-I.; Wu Y.-S.; Hou M.-F.; Wu S.-J.; Hsu S.-C.; Ko B.-S.; Chou W.-C.; Yao M.; Hou H.-A.; Tang J.-L.; Tien H.-F. | Bone Marrow Transplantation | | | |
| 2014 | EORTC QLQ-BM22 quality of life evaluation and pain outcome in patients with bone metastases from breast cancer treated with zoledronic acid | Yeh D.-C.; Chen D.-R.; Chao T.-Y.; Chen S.-C.; Wang H.-C.; Rau K.-M.; Feng Y.-H.; Chang Y.-C.; Lee K.-D.; Ou-Yang F.; WEN-HUNG KUO ; Chang K.-J.; Lin Y.-C.; Tseng L.-M.; Hou M.-F. | In Vivo | | | |
| 2006 | Evolution of breast cancer screening in countries with intermediate and increasing incidence of breast cancer | Wu G.H.-M.; Chen L.-S.; Chang K.-J.; Hou M.-F.; Chen S.-C.; Liu T.-J.; CHIUN-SHENG HUANG ; Hsu G.-C.; Yu C.-C.; Jeng L.-L.; Chen S.-T.; Chou Y.-H.; Wu C.-Y.; Shin-Lan K.; Chen T.H.-H. | Journal of Medical Screening | | | |
| 2006 | Evolution of breast cancer screening in countries with intermediate and increasing incidence of breast cancer | Wu G.H.-M.; Chen L.-S.; Chang K.-J.; Hou M.-F.; Chen S.-C.; Liu T.-J.; Huang C.-S.; Hsu G.-C.; Yu C.-C.; Jeng L.-L.; Chen S.-T.; Chou Y.-H.; Wu C.-Y.; Shin-Lan K.; Chen, Tony Hsiu Hsi | Journal of Medical Screening | | | |
| 2021 | Evolutionary trajectories and genomic divergence in localized breast cancers after ipsilateral breast tumor recurrence | Wu C.-H.; Yeh H.-T.; Hsieh C.-S.; Huang C.-C.; Chattopadhyay A.; Chung Y.-C.; Tu S.-H.; Li Y.-H.; Lu T.-P.; Liang-Chuan Lai ; Hou M.-F.; Chang K.-J.; Tsai M.-H.; Chuang E.Y. | Cancers | | | |
| 2021 | Evolutionary trajectories and genomic divergence in localized breast cancers after ipsilateral breast tumor recurrence | Wu C.-H.; Yeh H.-T.; Hsieh C.-S.; Huang C.-C.; Chattopadhyay A.; Chung Y.-C.; Tu S.-H.; Li Y.-H.; TZU-PIN LU ; Lai L.-C.; Hou M.-F.; Chang K.-J.; Tsai M.-H.; Chuang E.Y. | Cancers | | | |
| 2013 | Factors influencing health related quality of life in cancer patients with bone metastases | Wong E.; Chow E.; Zhang L.; Bedard G.; Lam K.; Fairchild A.; Vassiliou V.; Alm El-Din M.A.; Jesus-Garcia R.; Kumar A.; Forges F.; Tseng L.-M.; Hou M.-F.; WEI-CHU CHIE ; Bottomley A. | Journal of Palliative Medicine | 16 | | |
